Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...
Shares of Tectonic Therapeutic Inc. (NASDAQ:TECX) closed Jan. 30 at $54.84, up $29.12, or 113%, on what Leerink analyst David ...
Continuing a cascade of positive news for Stereotaxis Inc., the company reported the first order for its petite Genesisx robot in Europe. The system received CE mark in August, but management held off ...
Latest data shows the largest indicative borrow rate increases among liquid option names include: Veru (VERU) 2.09% +0.85, NovaDel Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback